Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Free Report)’s share price was up 3,233.3% during mid-day trading on Thursday . The company traded as high as $0.2501 and last traded at $0.25. Approximately 49,003 shares were traded during trading, an increase of 198% from the average daily volume of 16,434 shares. The stock had previously closed at $0.0075.
Ampio Pharmaceuticals Price Performance
The firm has a market capitalization of $283,750.00, a price-to-earnings ratio of -0.02 and a beta of 5.61. The business’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.01.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc is a clinical‐stage biopharmaceutical company focused on developing therapies that modulate the body’s inflammatory response to alleviate pain and improve functional outcomes. Headquartered in Englewood, Colorado, the company leverages proprietary plasma‐derived and synthetic formulations to target chronic musculoskeletal and cardiovascular conditions.
The company’s lead product candidate, Ampion, is a novel, low‐molecular‐weight fraction of human serum albumin designed as a single intra‐articular injection for patients suffering from osteoarthritis of the knee.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- How the Rich Retire
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
